Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Aziz Shaibani"'
Autor:
David Michelson, William W. Chin, Robert H. Dworkin, Roy Freeman, David N. Herrmann, Ralph Mazitschek, Rodica Pop-Busui, Aziz Shaibani, James Vornov, Melissa Jones, Matthew Jarpe, Brittany Hader, Theresa Viera, Michelle Hylan, Tim Kachmar, Simon Jones
Publikováno v:
PAIN Reports, Vol 8, Iss 6, p e1114 (2023)
Abstract. Introduction:. Current treatments for painful diabetic peripheral neuropathy (DPN) are insufficiently effective for many individuals and do not treat nonpain signs and symptoms. The enzyme histone deacetylase type 6 (HDAC6) may play a role
Externí odkaz:
https://doaj.org/article/43d645a10fbd4b539890e51d56390ee1
Publikováno v:
BMJ Open, Vol 13, Iss 10 (2023)
Objectives This review aimed to summarise the existing knowledge about placebo and nocebo effects associated with pharmacological interventions and their mechanisms.Design Umbrella review, adopting the Assessment of Multiple Systematic Reviews 2 tool
Externí odkaz:
https://doaj.org/article/3ffe7965509e40e8bca61ac624c2c91e
Autor:
John A. Kessler, Aziz Shaibani, Christine N. Sang, Mark Christiansen, David Kudrow, Aaron Vinik, Nari Shin, the VM202 study group
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 3, Pp 1176-1184 (2021)
Abstract VM202 is a plasmid DNA encoding two isoforms of hepatocyte growth factor (HGF). A previous phase II study in subjects with painful diabetic peripheral neuropathy (DPN) showed significant reductions in pain. A phase III study was conducted to
Externí odkaz:
https://doaj.org/article/2329437b42c343839e9410cee955d372
Autor:
Youngran Kim, Xiaojin Li, Yan Huang, Minseon Kim, Aziz Shaibani, Kazim Sheikh, Guo-Qiang Zhang, Thy Phuong Nguyen
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundMyasthenia gravis (MG) is an autoimmune, neuromuscular condition and patients with MG are vulnerable due to immunosuppressant use and disease manifestations of dyspnea and dysphagia during the coronavirus disease 2019 (COVID-19) pandemic.Me
Externí odkaz:
https://doaj.org/article/07288f91ee044f209d43daded0e605de
Publikováno v:
Swiss Medical Weekly, Vol 150, Iss 3536 (2020)
Although placebos have long been considered a nuisance in clinical research, over recent years they have become an active and productive field of research. Indeed, the placebo effect represents an elegant model to understand how the brain works. It i
Externí odkaz:
https://doaj.org/article/ce5c5398553e40c59ae2deeb429ab660
Publikováno v:
Pain. 164:984-990
Open-label placebos, or placebos without deception, have been found to induce analgesia, a challenging concept that need to be investigated in detail. In particular, what we need to know is the mechanism through which analgesia is induced when no dec
Publikováno v:
Thursday, April 27.
Autor:
Elisa Frisaldi, Jan Vollert, Husam Al Sultani, Sowsan Hafuth, Fabrizio Benedetti, Aziz Shaibani
Publikováno v:
Tuesday, April 25.
Publikováno v:
Clinical Pain Management. :60-66
Publikováno v:
Annual Review of Pharmacology and Toxicology. 62:323-340
Over the past 30 years there has been a surge of research on the placebo effect using a neuroscientific approach. The interesting aspects of this effort are related to the identification of several biological mechanisms of both the placebo and nocebo